ResMed reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ResMed using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-10-30 | $2.55 | $2.50 | 2.00 % |
| Q4 | 2025-07-31 | $2.55 | $2.47 | 3.24 % |
| Q3 | 2025-04-23 | $2.37 | $2.36 | 0.42 % |
| Q2 | 2025-01-30 | $2.43 | $2.31 | 5.19 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-10-30 | $1.34B | $1.33B | 0.62 % |
| Q4 | 2025-07-31 | $1.35B | $1.33B | 1.63 % |
| Q3 | 2025-04-23 | $1.29B | $1.28B | 0.94 % |
| Q2 | 2025-01-30 | $1.28B | $1.27B | 0.94 % |
ResMed (RMD) is scheduled to report earnings on January 29, 2026. The last reported earnings were for reported on October 30, 2025 for Q1.
The Actual EPS was $2.55, which beat the estimate of $2.50.
The Actual Revenue was $1.3B, which beat the estimate of $1.3B.
Browse earnings estimates, EPS, and revenue on all stocks.